A new study uncovers how targeting a specific immune cell surface receptor, PD-1, can enhance the effectiveness of cancer treatments by limiting its activity. Additionally, these insights lend support to emerging treatment approaches for autoimmune diseases conditions where the immune system mistake
'Double life' of key immune protein reveals new strategies for treating cancer and autoimmune diseases sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.
Insights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengthened to improve their anticancer effect, a new study shows.
/PRNewswire/ NYU Grossman School of Medicine s Vilcek Institute of Graduate Biomedical Sciences and Sarah Lawrence College today announced the launch of a.